🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused action to address household expense pressures" in next month's Budget.

During an interview with media outlets, she emphasized that lowering price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the highest among the G7 industrialized countries this calendar year and the following year.

Possible Energy Bill Interventions

Sources suggest the government could intervene to bring down energy bills, for example by slashing the present 5% level of VAT charged on energy supplies.

Another possibility is to reduce some of the government charges currently added to household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for these measures.

The consensus from most experts is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on the same day, analysis suggested there was a £22 billion gap for the Treasury chief to resolve, which is at the lower end of projections.

"It is a shared task between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor stated to reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on expected tax increases, the Treasury chief said the latest figures from the OBR had not changed her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with rising international and commercial tensions for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always are paramount."

Recent statement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are key for advanced tech production led American leader Donald Trump to threaten an additional 100% import tax on goods from China, increasing the prospect of an full-scale commercial conflict between the two largest economies.

The American finance chief described the Chinese action "economic coercion" and "a international production control attempt."

Asked about accepting the US offer to participate in its conflict with China, the Chancellor said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the move was "damaging for the global economy and causes further challenges."

"It is my opinion there are areas where we need to confront Chinese policies, but there are also significant prospects to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that balance correct."

The chancellor also confirmed she was working with G7 counterparts "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

The Chancellor also acknowledged that the price the National Health Service spends on pharmaceuticals could go up as a consequence of current negotiations with the US government and its drugs companies, in return for lower tariffs and funding.

A number of the biggest global drug companies have said lately that they are either halting or scrapping operations in the UK, with some attributing the low prices they are getting.

Recently, the Science Minister said the price the health service spends on medicines would have to rise to stop companies and pharmaceutical investment departing from the UK.

The Chancellor told the BBC: "It has been observed due to the payment system, that clinical trials, recent pharmaceuticals have not been provided in the UK in the way that they are in other EU nations."

"We want to guarantee that patients getting treatment from the NHS are can obtain the finest essential treatments in the globe. And so we are examining this situation, and... seeking to attract more funding into Britain."